HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Table All Versions of this Article: 2005-0139v1 24/2/406    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guo, J.-K. Articles by Krause, D. S. Search for Related Content PubMed PubMed Citation Articles by Guo, J.-K. Articles by Krause, D. S.

TRANSLATIONAL AND CLINICAL RESEARCH

Bone Marrow Transplantation Can Attenuate the Progression of Mesangial Sclerosis

^a Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA;
^b INSERM U 636, Center for Biochemistry, Nice University, Nice, France

Key Words. Kidney failure • Bone marrow transplantation • Tissue regeneration

Correspondence: Diane S. Krause, M.D. Ph.D., 333 Cedar Street, P.O. Box 208035, New Haven, Connecticut 06520, USA. Telephone: 1-203-688-4829; Fax: 1-203-688-2748; e-mail: diane.krause{at}yale.edu

Bone marrow (BM) transplantation has been shown to provide beneficial effects in injured organs, including heart, liver, and kidney. We explored the therapeutic potential of BM transplantation (BMT) in Wilms’ tumor suppressor 1 (Wt1) heterozygous mice, which represent a model of mesangial sclerosis. After transplantation of wild-type BM, there is statistically significantly lower urinary albumin and increased survival in Wt1^+/– recipients. Control BMT using Wt1^+/– donors showed no significant beneficial effects. The long-term beneficial effect of BMT was dependent on the dose of irradiation applied to the recipients before BMT. At a lethal dose of 1,000 cGy, the decrease in albuminuria and prolongation of lifespan in Wt1^+/– mice were transient, with maximal amelioration at 12 weeks and resumption of albuminuria by 24 weeks after BMT. This was, at least in part, due to irradiation and not Wt1 heterozygosity because wild-type recipients also developed albuminuria within 24 weeks of BMT with 1,000 cGy. In contrast, Wt1^+/– mice transplanted after 400 cGy showed long-term improvement in albuminuria and lifespan. Approximately 0.4% of podocytes were marrow derived, a level that is unlikely to be responsible for the therapeutic effects. In addition, donor BM cells formed rings surrounding the glomeruli, and approximately one third of the cells in these rings were macrophages. In conclusion, transplantation of wild-type BM attenuates progression of mesangial sclerosis in the Wt1^+/– model of renal disease, and the mechanism by which this occurs may involve engraftment of BM-derived cells in the renal parenchyma.

This article has been cited by other articles:

				K. Katayama, M. Kawano, I. Naito, H. Ishikawa, Y. Sado, N. Asakawa, T. Murata, K. Oosugi, M. Kiyohara, E. Ishikawa, et al. Irradiation Prolongs Survival of Alport Mice J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1692 - 1700. [Abstract] [Full Text] [PDF]

				H. Du and H. S. Taylor Contribution of Bone Marrow-Derived Stem Cells to Endometrium and Endometriosis Stem Cells, August 1, 2007; 25(8): 2082 - 2086. [Abstract] [Full Text] [PDF]

				E. I. Prodromidi, R. Poulsom, R. Jeffery, C. A. Roufosse, P. J. Pollard, C. D. Pusey, and H. T. Cook Bone Marrow-Derived Cells Contribute to Podocyte Regeneration and Amelioration of Renal Disease in a Mouse Model of Alport Syndrome Stem Cells, November 1, 2006; 24(11): 2448 - 2455. [Abstract] [Full Text] [PDF]